Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study
Ryan J.O. Dowling(University Health Network), Vuk Stambolic(University Health Network)
Cited by 118
Related Papers
Nuclear PTEN Controls DNA Repair and Sensitivity to Genotoxic Stress
|Science|2013|410
Metformin in cancer: translational challenges
|Journal of Molecular Endocrinology|2012|351
The Rho Guanine Nucleotide Exchange Factor DRhoGEF2 Is a Genetic Modifier of the PI3K Pathway in Drosophila
|PLoS ONE|2016|4
NEK10 tyrosine phosphorylates p53 and controls its transcriptional activity
|bioRxiv (Cold Spring Harbor Laboratory)|2019|3
The role of mTOR signalling in translational control and cancer
|Library and Archives Canada (Government of Canada)|2009|0